HER2 ultralow breast cancer

1 trials 1 recruiting MedDRA PT
1 Registered trials
1 Recruiting
1 Unique sponsors
1 Unique IMPs
1 Commercial trials
Drug classes (ATC)
— ATC code not specified 1
Mechanism of action (INN-stem analysis)
Antibody-drug conjugate (ADC) 1 substance
Phase I/II: 1

Filter these 1 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 1 trials

Phase I/II

1 trial
  • Pfizer Inc. Commercial
    DISITAMAB VEDOTIN
    2025-521003-52-00 3 countries 2025 n=26
    Recruiting
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Pfizer Inc. Commercial 1 Phase I/II 1
New trials by year
2025
1
← All indication landscapes